WASHINGTON — Drugmakers, device companies and health insurers all got some good news when Democrats in the U.S. House of Representatives released changes to healthcare reform legislation on Thursday. Hefty taxes on those three industries were delayed by at least a year, among other adjustments to the bill that seeks to overhaul the nation’s healthcare system. Following are some of the winners and losers for the healthcare industry based on the reconciliation bill the House is considering along with the Senate’s bill. A vote is expected on Sunday. WINNERS BRANDNAME DRUGMAKERS * The pharmaceutical industry largely keeps its $80 billion agreement to provide savings and rebates. Its fees, to be parceled out among companies such as Pfizer Inc and Merck & Co Inc, would be delayed from 2010 to 2011, increasing from the initial $2.3 billion a year to $2.7 billion. * Overall, wider insurance coverage could help offset the costs by providing more potential customers. * Drugmakers warded off deeper price cuts in the Medicare program for the elderly. The House had sought to fully close the so-called ‘doughnut hole’ where coverage drops temporarily after reaching a spending limit, but the bill […]

Read the Full Article